AstraZeneca PLC Operating Expenses 2011-2026 | AZN

Annual Operating Expenses AstraZeneca PLC

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	17.6 B	17.8 B	15.6 B	15.9 B	15.3 B	16.9 B	18.1 B	16.8 B	14.4 B	17 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18.1 B	14.4 B	16.5 B

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	20.7 M	$ 0.79	-1.15 %	$ 4.31 M	China
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
AbCellera Biologics ABCL	292 M	$ 3.49	0.58 %	$ 1.04 B	Canada
Frequency Therapeutics FREQ	128 M	-	-	$ 528 M	USA
argenx SE ARGX	2.27 B	$ 700.45	-1.19 %	$ 25 B	Niderland
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.6	1.41 %	$ 8.66 B	Australia
Grifols, S.A. GRFS	1.64 B	$ 7.81	-2.01 %	$ 6.83 B	Spain
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Ascendis Pharma A/S ASND	338 M	$ 225.98	-1.32 %	$ 5 B	Danmark
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
ADC Therapeutics SA ADCT	334 M	$ 4.13	-5.06 %	$ 105 M	Schweiz
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
BioCardia BCDA	15.7 M	$ 1.26	-0.79 %	$ 26.7 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Anika Therapeutics ANIK	51.6 M	$ 14.2	-0.7 %	$ 208 M	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
BioNTech SE BNTX	512 M	$ 91.19	1.21 %	$ 27.2 B	Germany
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.44	-1.37 %	$ 367 M	Britain
Arcturus Therapeutics Holdings ARCT	158 M	$ 6.68	-4.57 %	$ 183 M	Israel
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
AVEO Pharmaceuticals AVEO	44.9 M	-	-	$ 521 M	USA
Burford Capital Limited BUR	106 M	$ 7.92	1.67 %	$ 1.31 B	Britain
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	53.7 M	$ 2.54	-5.22 %	$ 16 M	USA
Certara CERT	237 M	$ 6.67	1.6 %	$ 1.07 B	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 3.6	-4.0 %	$ 7.83 B	Israel
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA